| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6e12ef0d19f650c11180a2a7a820ad3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2123-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0493
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-743 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B59-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
1993-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1996-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbb1d47a87d6de0511b6f72c41382e1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b86238f1a2221db253ea4069ded4f3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52414ec3d332f5957188771d246256a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_168b946c2e27dc237ef09949d64398b0 |
| publicationDate |
1996-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5554602-A |
| titleOfInvention |
Labelling of hormones with rhenium and tecnetium |
| abstract |
The disclosed invention is drawn to the organometallic oestrogen complex of formula (I): <IMAGE> (I) in which A is a C1-7 alkylene radical or C2-7 alkenylene or alkynylene radical; Mx is one or more identical or different transition metals; L'y is one or more identical or different ligands complexing the metal(s) of Mx; and L is a ligand for covalently coupling Mx to A; and R is H or a C1-7 alkyl or alkoxy group which may be optionally substituted, particularly with one or more halogens. These complexes are useful for the treatment of hormone-dependent cancers. Also, when the metals of the complex Mx are radioactive isotopes suitable for imaging, the complexes are useful as imaging agents. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004241087-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10535434-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6534037-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5928499-A |
| priorityDate |
1992-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |